DrugCite

Alaway and Diplopia

This page shows results related to Alaway and Diplopia from the FDA Adverse Event Reporting System (AERS). The adverse event Diplopia has been reported to the FDA a total of 2 times for Alaway.

Learn More About Alaway Adverse Events

Safety Comparison of Diplopia in Alaway and Related Drugs

The Proportional Reporting Ratio (PRR) for Alaway and Diplopia is 3. The chart below compares this proportional reporting ratio of Diplopia for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Diplopia.

Diplopia
Alaway
3

NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.

People Reporting Diplopia Used Alaway For the Following Reasons

Of those reporting Diplopia, why were they taking Alaway?

Seasonal Allergy
2


Scientific Publications on Diplopia

Powered by Google